Peter P. Sayeski

2.3k total citations
76 papers, 1.8k citations indexed

About

Peter P. Sayeski is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Peter P. Sayeski has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 43 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in Peter P. Sayeski's work include Cytokine Signaling Pathways and Interactions (44 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers) and Protein Kinase Regulation and GTPase Signaling (22 papers). Peter P. Sayeski is often cited by papers focused on Cytokine Signaling Pathways and Interactions (44 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers) and Protein Kinase Regulation and GTPase Signaling (22 papers). Peter P. Sayeski collaborates with scholars based in United States, Hungary and United Kingdom. Peter P. Sayeski's co-authors include Kenneth E. Bernstein, Mohammad Ali, Jeffrey E. Kudlow, Eric M. Sandberg, Mario B. Marrero, Stuart J. Frank, Xianyue Ma, David J. Hayzer, Rebekah Baskin and Kai He and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Peter P. Sayeski

75 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter P. Sayeski United States 27 980 575 334 314 285 76 1.8k
Hong Ju United States 21 1.3k 1.3× 207 0.4× 663 2.0× 200 0.6× 206 0.7× 25 2.5k
William G. Paxton United States 12 1.0k 1.1× 353 0.6× 724 2.2× 105 0.3× 335 1.2× 13 1.6k
Françoise Bono France 29 1.3k 1.3× 380 0.7× 341 1.0× 252 0.8× 119 0.4× 65 2.7k
Albrecht Moritz United States 13 1.8k 1.9× 257 0.4× 290 0.9× 62 0.2× 344 1.2× 16 2.7k
Lawrence S. Argetsinger United States 23 1.4k 1.4× 1.2k 2.1× 193 0.6× 194 0.6× 1.3k 4.5× 40 3.0k
Patrick E. Ward United States 27 747 0.8× 621 1.1× 384 1.1× 557 1.8× 256 0.9× 53 1.7k
Robert T. Dorsam United States 18 1.3k 1.3× 432 0.8× 634 1.9× 130 0.4× 120 0.4× 22 2.6k
D. Kirk Ways United States 24 1.6k 1.6× 269 0.5× 288 0.9× 71 0.2× 205 0.7× 44 2.3k
Alan Cheng United States 26 1.9k 1.9× 593 1.0× 224 0.7× 113 0.4× 207 0.7× 45 3.1k
Chandi Griffin United States 26 1.3k 1.3× 265 0.5× 951 2.8× 294 0.9× 717 2.5× 48 2.6k

Countries citing papers authored by Peter P. Sayeski

Since Specialization
Citations

This map shows the geographic impact of Peter P. Sayeski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Sayeski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Sayeski more than expected).

Fields of papers citing papers by Peter P. Sayeski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. Sayeski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Sayeski. The network helps show where Peter P. Sayeski may publish in the future.

Co-authorship network of co-authors of Peter P. Sayeski

This figure shows the co-authorship network connecting the top 25 collaborators of Peter P. Sayeski. A scholar is included among the top collaborators of Peter P. Sayeski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter P. Sayeski. Peter P. Sayeski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnston, Jermaine G., et al.. (2023). Aldosterone: Renal Action and Physiological Effects. Comprehensive physiology. 13(2). 4409–4491. 11 indexed citations
2.
Kobayashi, Susumu, Shireen Vali, Ansu Kumar, et al.. (2016). Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines. Oncotarget. 7(24). 35989–36001. 7 indexed citations
3.
Klein, Sabine, Jennifer Lehmann, Robert Schierwagen, et al.. (2015). Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis. Gut. 66(1). 145–155. 55 indexed citations
4.
Park, Sung O, Heather L. Wamsley, Kyung‐Mi Bae, et al.. (2013). Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans. PLoS ONE. 8(3). e59675–e59675. 49 indexed citations
5.
Magis, Andrew T., et al.. (2012). A shift in the salt bridge interaction of residues D620 and E621 mediates the constitutive activation of Jak2-H538Q/K539L. Molecular and Cellular Biochemistry. 367(1-2). 125–140. 3 indexed citations
6.
Kirabo, Annet, Sung O Park, Heather L. Wamsley, et al.. (2012). The Small Molecule Inhibitor G6 Significantly Reduces Bone Marrow Fibrosis and the Mutant Burden in a Mouse Model of Jak2-Mediated Myelofibrosis. American Journal Of Pathology. 181(3). 858–865. 6 indexed citations
7.
Kirabo, Annet, Sung O Park, Anurima Majumder, et al.. (2011). The Jak2 Inhibitor, G6, Alleviates Jak2-V617F–Mediated Myeloproliferative Neoplasia by Providing Significant Therapeutic Efficacy to the Bone Marrow. Neoplasia. 13(11). 1058–1068. 9 indexed citations
8.
Baskin, Rebekah, et al.. (2010). The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors. Current Medicinal Chemistry. 17(36). 4551–4558. 30 indexed citations
9.
Sayyah, Jacqueline & Peter P. Sayeski. (2009). Jak2 inhibitors: Rationale and role as therapeutic agents in hematologic malignancies. Current Oncology Reports. 11(2). 117–124. 21 indexed citations
10.
Sayyah, Jacqueline, Andrew T. Magis, David A. Ostrov, et al.. (2008). Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. Molecular Cancer Therapeutics. 7(8). 2308–2318. 20 indexed citations
11.
Ma, Xianyue, et al.. (2008). Identification of Tyrosine 972 as a Novel Site of Jak2 Tyrosine Kinase Phosphorylation and Its Role in Jak2 Activation. Biochemistry. 47(32). 8326–8334. 8 indexed citations
12.
Frenzel, Kristen, Tiffany A. Wallace, Hong Xiao, et al.. (2006). A functional Jak2 tyrosine kinase domain is essential for mouse development. Experimental Cell Research. 312(15). 2735–2744. 9 indexed citations
13.
Sayeski, Peter P., et al.. (2006). ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCζ-controlled ERK1/2 activity within the nucleus. American Journal of Physiology-Cell Physiology. 291(6). C1297–C1307. 29 indexed citations
14.
Sandberg, Eric M., et al.. (2004). Jak2 Tyrosine Kinase: A True Jak of All Trades?. Cell Biochemistry and Biophysics. 41(2). 207–232. 39 indexed citations
15.
Wallace, Tiffany A., et al.. (2004). Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression. American Journal of Physiology-Cell Physiology. 287(4). C981–C991. 18 indexed citations
16.
Sayeski, Peter P.. (2003). The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation. Experimental Cell Research. 287(2). 339–349. 45 indexed citations
17.
Ma, Xianyue, et al.. (2002). Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity. Molecular and Cellular Biochemistry. 241(1-2). 87–94. 11 indexed citations
18.
Sayeski, Peter P., Mohammad Ali, Stuart J. Frank, & Kenneth E. Bernstein. (2001). The Angiotensin II-dependent Nuclear Translocation of Stat1 Is Mediated by the Jak2 Protein Motif231YRFRR. Journal of Biological Chemistry. 276(13). 10556–10563. 27 indexed citations
19.
Bernstein, Kenneth E., et al.. (1998). New insights into the cellular signaling of seven transmembrane receptors: the role of tyrosine phosphorylation.. PubMed. 78(1). 3–7. 21 indexed citations
20.
Ali, Mohammad, et al.. (1997). Dependence on the Motif YIPP for the Physical Association of Jak2 Kinase with the Intracellular Carboxyl Tail of the Angiotensin II AT1 Receptor. Journal of Biological Chemistry. 272(37). 23382–23388. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Ju Breakdown of academic impact, for papers by William G. Paxton Breakdown of academic impact, for papers by Françoise Bono Breakdown of academic impact, for papers by Albrecht Moritz Breakdown of academic impact, for papers by Lawrence S. Argetsinger Breakdown of academic impact, for papers by Patrick E. Ward Breakdown of academic impact, for papers by Robert T. Dorsam Breakdown of academic impact, for papers by D. Kirk Ways Breakdown of academic impact, for papers by Alan Cheng Breakdown of academic impact, for papers by Chandi Griffin
Rankless by CCL
2026